Description

Tirzepatide 60mg

Tirzepatide 60mg is a high-potency research-grade dual-agonist peptide designed exclusively for laboratory and scientific research. Known in literature for its interaction with GIP and GLP-1 receptor pathways, this higher-strength vial is well suited for extended, multi-phase, or comparative research protocols that require consistency, purity, and stability. Supplied strictly for research use only (RUO).

Key Features

• 60mg high-strength research vial

• Dual-pathway peptide (GIP & GLP-1 research focus)

• Lyophilized powder for enhanced stability

• Suitable for long-term and advanced research designs

• Batch-tested for purity and consistency

Research Uses

Tirzepatide is frequently referenced in scientific studies related to:

• Dual GIP/GLP-1 receptor pathway research

• Metabolic signaling and endocrine system studies

• Glucose regulation research models

• Energy balance and appetite signaling mechanisms

 Disclaimer: This product is intended strictly for laboratory research purposes only. Not for human or veterinary use.

Home Page

Product Specifications

• Product Name: Tirzepatide

• Strength: 60mg

• Form: Lyophilized powder

• Grade: Research Use Only (RUO)

• Storage: Store in a cool, dry environment; refrigerate after reconstitution per laboratory standards

USA Shipping & Availability

• Fast and secure USA domestic shipping

• Discreet, professional laboratory packaging

• Available to qualified research labs and institutions within the United States

Advantages and Disadvantages

Advantages

• High concentration for extended or repeated research protocols

• Supports advanced dual-receptor research models

• Cost-effective option for large-scale USA research projects

Disadvantages

• Not approved for clinical, diagnostic, or therapeutic use

• Requires proper laboratory handling and controlled storage